Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学RNAseq Profiling, Breast Cancer

Matthew Ellis

MB BChir, PhD

🏢AstraZeneca (formerly Baylor College of Medicine)🌐USA

Director, Translational Research, AstraZeneca Oncology

120
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Matthew Ellis led CPTAC breast cancer proteogenomics and has shaped understanding of ER-positive luminal breast cancer biology and endocrine therapy response. Formerly at Baylor, he now leads translational research at AstraZeneca Oncology. He is a leader in multi-omic breast cancer profiling.

Share:

🧪Research Fields 研究领域

breast cancer proteogenomics
luminal breast cancer
CPTAC breast
aromatase inhibitors
ER positive biology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Matthew Ellis 的研究动态

Follow Matthew Ellis's research updates

留下邮箱,当我们发布与 Matthew Ellis(AstraZeneca (formerly Baylor College of Medicine))相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment